Share on StockTwits

Analysts’ upgrades for Wednesday, June 25th:

Alstom Unsp (OTCMKTS:ALSMY) was upgraded by analysts at Deutsche Bank from a hold rating to a buy rating.

Brunswick (NYSE:BC) was upgraded by analysts at ISI Group from a hold rating to a buy rating. The firm currently has $55.00 price target on the stock.

Companhia Paranaense de Energia (NYSE:ELP) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. Zacks currently has $18.00 price target on the stock. Zacks’ analyst wrote, “COPEL has solid long-term growth prospects, especially in the light of an anticipated rise of 5.9% in the annual electricity demand in Brazil. Also, with revival in the economic health of the country, huge investments are being made for infrastructural developments that, in turn, will boost electricity demand. To benefit from growing electricity needs, COPEL has planned investments worth roughly R$2.6 billion for 2014, in order to improve its electricity generation capacity. In this regard, the recent agreement for a 49% stake acquisition in Voltalia’s wind farm complex is worth mentioning. Considering all these factors as well as the company’s stellar performance in first-quarter 2014, with net earnings and revenues increasing by 46% and 28% respectively, we upgrade our recommendation from Neutral to Outperform on COPEL. “

Evercore Partners (NYSE:EVR) was upgraded by analysts at Sandler O’Neill from a hold rating to a buy rating.

Greenhill & Co. (NYSE:GHL) was upgraded by analysts at Sandler O’Neill from a hold rating to a buy rating.

The Hain Celestial Group (NASDAQ:HAIN) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. Zacks currently has $95.00 target price on the stock.

Hanesbrands (NYSE:HBI) was upgraded by analysts at Brean Capital from a hold rating to a buy rating. The firm currently has $110.00 price target on the stock.

ArcelorMittal SA (NYSE:MT) was upgraded by analysts at Zacks from an underperform rating to a neutral rating. The firm currently has $16.00 target price on the stock.

QLogic (NASDAQ:QLGC) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. They currently have $12.00 price target on the stock. Zacks’ analyst wrote, “QLogic reported better-than-expected fourth-quarter fiscal 2014 results with both earnings and revenues beating the Zacks Consensus Estimate. Management provided an optimistic guidance for the first quarter of fiscal 2015. Though higher investments in engineering and intensifying competition will hurt profitability, yet we believe that QLogic will continue to benefit from contract wins from original equipment manufacturers (OEMs) in the near term. The acquisition of Brocade’s adapter business is expected to boost revenues in 2014 and beyond. Moreover, innovative product pipeline, new technologies and additional savings from its restructuring initiatives will drive profitability in the long run. Thus, we upgrade our recommendation from Neutral to Outperform and set a price target of $12.00. “

Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. Zacks currently has $334.00 price target on the stock. Zacks’ analyst wrote, “Regeneron’s first quarter 2014 adjusted earnings of $1.58 per share breezed past the Zacks Consensus Estimate of $0.99. Higher revenues boosted earnings in the first quarter of 2014. Total revenue in the quarter soared 42% to $626 million driven by year-over-year growth in the sales of eye drug, Eylea as well as impressive collaboration revenues. Regeneron continues to expect U.S. Eylea sales in the range of $1.7 billion to $1.8 billion in 2014. The company is seeking to expand the label of Eylea into other eye disorders. The company will also be moving to a tax-efficient operating model, the benefits of which should materialize from 2017. We believe that the current price represents an attractive entry point for long-term investors and are upgrading the stock to Outperform.”

Statoil ASA(ADR) (NYSE:STO) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. The firm currently has $38.00 price target on the stock. Zacks’ analyst wrote, “Statoil ASA reported strong first-quarter results with earnings beating the Zacks Consensus Estimate and revenues rising over the year-ago number. The growth is mainly attributable to increase in U.S. gas sales volumes and margins as well as higher prices for both liquids and gas. Statoil is gaining momentum with the start-up of operations on several new oil and gas fields. The company is also planning turnarounds on several oil and gas fields in 2014 to improve recovery of resources in mature fields. Moreover, Statoil boasts of a strong balance sheet, exited from low-profit generating operations and broadened its international asset base. The addition of new projects is expected to produce a CAGR growth rate of 2%-3% annually during the 2014 to 2016 period. Thus, we upgrade our recommendation from Neutral to Outperform and set a price target of $38.00.”

Walgreen Company (NYSE:WAG) was upgraded by analysts at Morgan Stanley from a hold rating to an overweight rating. The firm currently has $85.00 target price on the stock, up from their previous target price of $69.00. The analysts wrote, “Investor call at end of July/early August, providing the stage for WAG/AB management to unveil Step 2, is next catalyst for shares. Inversion, capital structure, and earnings roadmap are key to watch for. We reiterate our OW and would be buyers ahead of potential inversion event.”

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.